IP Library › Assignment 050974/0894
Patent Assignment
Reel/Frame 050974/0894

Assignment of Assignor's Interest

Recorded: 2019-11-11 Pages: 6
Assignor
CELGENE CORPORATION
Executed: 2019-10-14
Assignee
CELGENE QUANTICEL RESEARCH, INC.
9393 TOWN CENTRE DRIVE, SUITE 110, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (5)
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 15/673,084 →
Publication: US 2018/0125844
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 16/387,255 →
Publication: US 2019/0240222
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 16/387,318 →
Publication: US 2019/0240223
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 62/373,263 →
Treatment of Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas
Application: 62/468,424 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 19, 2016
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 039484/0664 →
Assignment of Assignor's Interest Mar 21, 2017
From: XU, JIANGCHUN; CHO, ROBERT; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 041658/0071 →
Assignment of Assignor's Interest Apr 5, 2018
From: XU, JIANGCHUN; NGUYEN, AARON
To: CELGENE CORPORATION
Reel/Frame 045452/0543 →
Assignment of Assignor's Interest Sep 19, 2018
From: QUANTICEL PHARMACEUTICALS, INC.
To: CELGENE CORPORATION
Reel/Frame 046912/0972 →
Employment Agreement Sep 19, 2018
From: CHO, ROBERT
To: QUANTICEL PHARMACEUTICALS, INC
Reel/Frame 047321/0235 →